Healthcare

Healthcare

Eli Lilly Sales Surge 56% as Booming GLP-1 Demand Eclipses Lower Prices

Photo via Kazuki Oishi/Sipa USA/Newscom

The results were driven by a 65% jump in volume amid a booming demand for weight-loss drugs like Lilly’s Mounjaro and Zepbound.

1 min read

Photo via Steven Garcia/ZUMAPRESS/Newscom

Healthcare

UnitedHealth Boosts Profit Forecast Without Committing to Medicare Obesity Drug Coverage

The company now expects 2026 adjusted earnings of more than $18.25 per share, a jump from the $17.75 per share it previously forecasted.

2 min read
Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Healthcare

Eli Lilly Invests Weight-Loss Windfall in Next-Gen Cancer Treatment

Kelonia is developing a next-gen blood cancer treatment that’ll reprogram T-cells to help patients’ immune systems fight cancer.

2 min read
Photo via Ritzau Scanpix/Sipa USA/Newscom

Artificial Intelligence

OpenAI Teams with Novo Nordisk to Speed Prescription Drug Development

The move comes as OpenAI watches rival Anthropic make big enterprise splashes with its Claude Code and Mythos AI tools.

2 min read

Healthcare

Neurocrine Scoops Up Hunger-Drug Maker in Latest Multi-Billion-Dollar Pharma Deal

Photo via Andre M. Chang/ZUMAPRESS/Newscom

Soleno Therapeutics’s Vykat XR is the first drug to be approved for treating the insatiable hunger caused by Prader-Willi Syndrome.

1 min read

Healthcare

Eli Lilly Widens Access to Weight-Loss Injectable as Lower-Cost Pill Nears Approval

Photo via Gado Images/Smith Collection/Gado/Sipa USA/Newscom

Just 20% of firms with 200 or more workers said they covered GLP-1 drugs for weight loss, according to the Peterson-KFF Health System Tracker.

2 min read

Healthcare

Moderna Spikes After FDA’s About-Face on mRNA Flu Vaccine

Photo via Spencer Jones/Plexi Images/GHI/UCG/Universal Images Group/Newscom

Just last week, the agency rejected Moderna’s initial application, citing flaws in the company’s research design.

2 min read

Sign Up for The Daily Upside to Unlock This Article

Sharp news & analysis on finance, economics, and investing.